{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T18:15:45Z","timestamp":1793988945800,"version":"4.8.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T00:00:00Z","timestamp":1674518400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Southeast Asia"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.lansea.2023.100162","type":"journal-article","created":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T14:54:56Z","timestamp":1677250496000},"page":"100162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Metronomic adjuvant chemotherapy evaluation in locally\u00a0advanced head and neck cancers post radical chemoradiation \u2013 a randomised trial"],"prefix":"10.1016","volume":"12","author":[{"given":"Vijay","family":"Patil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanita","family":"Noronha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandini","family":"Menon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijayalakshmi","family":"Mathrudev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atanu","family":"Bhattacharjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavita","family":"Nawale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1690-5336","authenticated-orcid":false,"given":"Deevyashali","family":"Parekh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shripad","family":"Banavali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8858-5004","authenticated-orcid":false,"given":"Kumar","family":"Prabhash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lansea.2023.100162_bib1","unstructured":"The International Agency for Research on Cancer (IARC). Global Cancer Observatory (GCO). https:\/\/gco.iarc.fr\/(accessed Dec 6, 2022) ."},{"key":"10.1016\/j.lansea.2023.100162_bib2","first-page":"4779","article-title":"Head and neck cancer: a global perspective on epidemiology and prognosis","volume":"18","author":"Sankaranarayanan","year":"1998","journal-title":"Anticancer Res"},{"key":"10.1016\/j.lansea.2023.100162_bib3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ijrobp.2013.12.027","article-title":"Final results of local-regional control and late toxicity of RTOG 9003: a randomized trial of altered fractionation radiation for locally advanced head and neck cancer","volume":"89","author":"Beitler","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.lansea.2023.100162_bib4","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.radonc.2009.04.014","article-title":"Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients","volume":"92","author":"Pignon","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.lansea.2023.100162_bib5","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1200\/JCO.2012.43.6097","article-title":"Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer","volume":"31","author":"Forastiere","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.lansea.2023.100162_bib13","doi-asserted-by":"crossref","first-page":"e1213","DOI":"10.1016\/S2214-109X(20)30275-8","article-title":"Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomised, phase 3 trial","volume":"8","author":"Patil","year":"2020","journal-title":"Lancet Global Health"},{"key":"10.1016\/j.lansea.2023.100162_bib6","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.ccell.2014.11.005","article-title":"Postsurgical adjuvant tumor therapy by combining anti-angiopoietin-2 and metronomic chemotherapy limits metastatic growth","volume":"26","author":"Srivastava","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.lansea.2023.100162_bib7","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4103\/0019-509X.117024","article-title":"Oral metronomic scheduling of anticancer therapy-based treatment compared to existing standard of care in locally advanced oral squamous cell cancers: a matched-pair analysis","volume":"50","author":"Pai","year":"2013","journal-title":"Indian J Cancer"},{"key":"10.1016\/j.lansea.2023.100162_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/biology10020168","article-title":"The overall efficacy and outcomes of metronomic tegafur-uracil chemotherapy on locally advanced head and neck squamous cell carcinoma: a real-world cohort experience","volume":"10","author":"Yeh","year":"2021","journal-title":"Biology"},{"key":"10.1016\/j.lansea.2023.100162_bib9","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0140-6736(21)01123-5","article-title":"Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial","volume":"398","author":"Chen","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.lansea.2023.100162_bib10","doi-asserted-by":"crossref","first-page":"52","DOI":"10.4103\/2278-330X.181625","article-title":"Outcome of operable oral cavity cancer and impact of maintenance metronomic chemotherapy: a retrospective study from rural India","volume":"5","author":"Pandey","year":"2016","journal-title":"South Asian J Cancer"},{"issue":"4","key":"10.1016\/j.lansea.2023.100162_bib11","article-title":"Oral uracil and tegafur as postoperative adjuvant metronomic chemotherapy in patients with advanced oral squamous cell carcinoma","volume":"10","author":"Lin","year":"2015","journal-title":"J\u00a0Dent Sci"},{"key":"10.1016\/j.lansea.2023.100162_bib12","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.3109\/00016489.2011.590153","article-title":"Consecutive daily low-dose S-1 adjuvant chemotherapy after radical treatment for squamous cell carcinoma in head and neck cancer","volume":"131","author":"Furusaka","year":"2011","journal-title":"Acta Otolaryngol"},{"key":"10.1016\/j.lansea.2023.100162_bib14","first-page":"163","volume":"39","author":"Noronha","year":"2021","journal-title":"J\u00a0Clin Orthod"},{"key":"10.1016\/j.lansea.2023.100162_bib15","doi-asserted-by":"crossref","first-page":"S789","DOI":"10.1016\/j.annonc.2021.08.1275","article-title":"RMAC study: a randomized study evaluating the efficacy of metronomic adjuvant chemotherapy in patients with recurrent head and neck cancers post salvage surgery, not eligible for re-irradiation","volume":"32","author":"Menon","year":"2021","journal-title":"Ann Oncol"},{"key":"10.1016\/j.lansea.2023.100162_bib16","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJMoa0912217","article-title":"Human papillomavirus and survival of patients with oropharyngeal cancer","volume":"363","author":"Ang","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.lansea.2023.100162_bib17","doi-asserted-by":"crossref","first-page":"399","DOI":"10.18632\/oncotarget.27443","article-title":"Nimotuzumab-cisplatin-radiation versus cisplatin-radiation in HPV negative oropharyngeal cancer","volume":"11","author":"Noronha","year":"2020","journal-title":"Oncotarget"},{"key":"10.1016\/j.lansea.2023.100162_bib18","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S1470-2045(13)70011-1","article-title":"Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial","volume":"14","author":"Haddad","year":"2013","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.lansea.2023.100162_bib19","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/annonc\/mdt461","article-title":"A\u00a0randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as treatment of unresectable head and neck cancer","volume":"25","author":"Hitt","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.lansea.2023.100162_bib20","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1200\/JCO.2013.54.6309","article-title":"Phase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancer","volume":"32","author":"Cohen","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.lansea.2023.100162_bib21","first-page":"5507","article-title":"A\u00a0phase III trial (RTOG 0129) of two radiation-cisplatin regimens for head and neck carcinomas (HNC): impact of radiation and cisplatin intensity on outcome","volume":"28","author":"Ang","year":"2010","journal-title":"J\u00a0Clin Orthod"},{"key":"10.1016\/j.lansea.2023.100162_bib22","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1200\/JCO.2013.53.5633","article-title":"Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522","volume":"32","author":"Ang","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.lansea.2023.100162_bib23","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S1470-2045(20)30737-3","article-title":"Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial","volume":"22","author":"Lee","year":"2021","journal-title":"Lancet Oncol"},{"issue":"32","key":"10.1016\/j.lansea.2023.100162_bib24","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1200\/JCO.19.01076","article-title":"Phase I\/II study of palliative triple metronomic chemotherapy in platinum-refractory\/early-failure oral cancer","volume":"37","author":"Patil","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.lansea.2023.100162_bib25","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1200\/JCO.22.01015","article-title":"Low-dose immunotherapy in head and neck cancer: a randomized study","volume":"41","author":"Patil","year":"2022","journal-title":"J\u00a0Clin Oncol"}],"container-title":["The Lancet Regional Health - Southeast Asia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772368223000227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772368223000227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T09:50:54Z","timestamp":1757411454000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772368223000227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":25,"alternative-id":["S2772368223000227"],"URL":"https:\/\/doi.org\/10.1016\/j.lansea.2023.100162","relation":{},"ISSN":["2772-3682"],"issn-type":[{"value":"2772-3682","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metronomic adjuvant chemotherapy evaluation in locally\u00a0advanced head and neck cancers post radical chemoradiation \u2013 a randomised trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Southeast Asia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lansea.2023.100162","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100162"}}